指南与共识消化、代谢与肾脏急症儿科与产科急症

阴茎异常勃起:第五次国际性医学咨询委员会(ICSM 2024)推荐意见

Priapism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).
指南 / 共识 · Sex Med Rev · 2026-01-01
一句话结论每位阴茎异常勃起患者均需急诊评估以区分急性缺血性与非缺血性,急性缺血性事件必要时应早期干预;非缺血性阴茎异常勃起不是急症,治疗应基于患者目标、现有资源和临床医生经验。

该推荐意见由第五次国际性医学咨询委员会(ICSM)第22委员会成员对2010至2025年同行评议文献进行综述,重点关注近十年发布的指南,经批判性审阅后形成。文件涵盖缺血性、非缺血性、复发性缺血性阴茎异常勃起及镰状细胞病患者阴茎异常勃起的循证诊断与治疗推荐,涉及影像学、实验室检查、急诊早期泌尿外科参与、保守治疗、患者咨询中勃起功能障碍与手术并发症风险的数据、海绵体内去氧肾上腺素联合或不联合灌洗的具体推荐、新手术技术及早期阴茎假体置入。结论强调每位患者均需急诊评估以确定急性缺血性或非缺血性,急性缺血性事件必要时应早期干预;非缺血性阴茎异常勃起的治疗基于患者目标、现有资源和临床医生经验,不是急症。

要点

  • 每位阴茎异常勃起患者均需急诊评估,以确定是急性缺血性还是非缺血性阴茎异常勃起。
  • 急性缺血性阴茎异常勃起必要时应接受早期干预。
  • 非缺血性阴茎异常勃起不是急症,治疗应基于患者目标、现有资源和临床医生经验。
  • 推荐意见涵盖缺血性、非缺血性、复发性缺血性阴茎异常勃起及镰状细胞病患者阴茎异常勃起的诊断与治疗。
  • 推荐内容包括海绵体内去氧肾上腺素联合或不联合灌洗的具体推荐、新手术技术及早期阴茎假体置入。

适用人群与场景

  • 缺血性阴茎异常勃起患者。
  • 非缺血性阴茎异常勃起患者。
  • 复发性缺血性阴茎异常勃起患者。
  • 镰状细胞病合并阴茎异常勃起的患者。

处置流程与药物剂量

  • 每位阴茎异常勃起患者均应接受急诊评估,以确定急性缺血性或非缺血性阴茎异常勃起。
  • 急性缺血性阴茎异常勃起患者必要时应接受早期干预。
  • 非缺血性阴茎异常勃起的治疗应基于患者目标、现有资源和临床医生经验,不是急症。

研究设计与关键结果

  • 第五次国际性医学咨询委员会(ICSM)第22委员会成员对同行评议科学文献进行综述,对2010至2025年文献及近十年指南进行批判性审阅和讨论,形成缺血性、非缺血性、复发性缺血性阴茎异常勃起及镰状细胞病患者阴茎异常勃起的循证诊断与治疗推荐。
  • 推荐意见涵盖影像学作用、实验室检测、患者到达急诊时早期泌尿外科参与、保守治疗讨论、关于勃起功能障碍和手术并发症风险患者咨询的改进数据、海绵体内去氧肾上腺素联合或不联合灌洗的具体推荐、新手术技术纳入及早期阴茎假体置入。

证据类型、等级与局限

  • 证据类型:指南(第五次国际性医学咨询委员会(ICSM 2024)推荐意见),基于对2010至2025年同行评议文献的综述及近十年指南的批判性审阅。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 急诊接诊阴茎异常勃起患者时应立即评估以区分急性缺血性与非缺血性,急性缺血性事件必要时应早期干预;非缺血性阴茎异常勃起不是急症,治疗应基于患者目标、现有资源和临床医生经验。
  • 患者到达急诊时应早期引入泌尿外科参与。
  • 应就勃起功能障碍和手术并发症风险向患者提供咨询。

指南或共识出处

  • Priapism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Male genital emergencies involving the penis are uncommon and necessitate immediate medical attention as well as surgery. The term "priapism" refers to a persistent erection caused by malfunctioning mechanisms that control rigidity, flaccidity, and penile tumescence. Identification of the underlying hemodynamics is necessary for a prompt and accurate diagnosis of priapism.

OBJECTIVES: To discuss the epidemiology, pathophysiology, and classification of priapism, as well as to give healthcare professionals up-to-date clinical evidence on the management of the priapism.

METHODS: The members of the Fifth International Consultation for Sexual Medicine (ICSM) Committee 22 have conducted a review of the peer-reviewed scientific literature to present an objective, comprehensive analysis regarding the diagnosis and management of priapism. This report reviews the literature from 2010 to 2025 on priapism and concentrates on guidelines that have been written in the last ten years. Every relevant article was examined critically and discussed.

RESULTS: This manuscript provides evidence-based diagnostic and treatment recommendations for ischemic, non-ischemic, recurrent ischemic priapism, and priapism in patients with sickle cell disease. The role of imaging, laboratory testing, early urologists' involvement when a patient presents to the emergency room, the discussion of conservative therapies, improved data for patient counseling regarding the risks of erectile dysfunction and surgical complications, specific recommendations regarding intra-cavernosal phenylephrine with or without irrigation, the inclusion of novel surgical techniques, and early penile prosthesis placement are all covered in this recommendation.

CONCLUSION: Every patient with priapism should have an emergency evaluation to determine whether they have acute ischemic or non-ischemic priapism, and those who have experienced an acute ischemic event should receive early intervention when necessary. Treatment for NIP must be based on the goals of the patient, the resources at hand, and the experience of the clinician; it is not an emergency.

来源:Sex Med Rev,查看原文。版权归原作者所有。

参考来源

  1. Kadioglu A, Kadihasanoglu M, Muneer A, et al. Priapism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024). Sex Med Rev. 2026. PMID: 41489159. doi:10.1093/sxmrev/qeaf072

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。